Utah chemists discover enzyme that could help build next-generation GLP-1 drugs - EurekAlert!
GLP-1 agonists pose emerging challenge for PET-CT imaging, study finds - EurekAlert!
New oral GLP-1 drugs could offer more options for weight loss
Alpha cells moonlight as secret GLP-1 factories - EurekAlert!
Cleveland Clinic study shows greater long-term benefits of bariatric surgery compared to GLP-1 medicines - EurekAlert!
Cleveland Clinic study shows greater long-term benefits of bariatric surgery compared to GLP-1 medicines - EurekAlert!
GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity - EurekAlert!
Efficacy and safety of GLP-1 RAs in children and adolescents with obesity or type 2 diabetes - EurekAlert!
GLP-1 weight-loss drugs pose hidden risks for young women - EurekAlert!
GLP-1 RAs and cardiovascular and kidney outcomes by body mass index in type 2 diabetes - EurekAlert!
As insurers struggle with GLP-1 drug costs, some seek to wean patients off
GLP-1 drugs reduce risk of death and hospitalization in patients with heart failure - EurekAlert!
Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity
Experts recommend SGLT-2 and GLP-1 diabetes drugs only for adults at moderate to higher risk of heart and kidney problems - EurekAlert!
GLP-1 receptor agonists and sight-threatening ophthalmic complications in patients with type 2 diabetes - EurekAlert!
GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes - EurekAlert!
GLP-1 drugs fail to provide key long-term health benefit - EurekAlert!
Survey shows GLP-1 weight-loss drugs are changing sex and dating for 50-60% of users - EurekAlert!
Study finds patients with interrupted GLP-1 access still achieve significant weight loss - EurekAlert!
Hundreds of weight loss and diabetes jab users report pancreas problems. Some cases of pancreatitis reported to be linked to GLP-1 medicines have been fatal.
